CLEO Diagnostics kicks off ovarian cancer-detecting blood test trials in USA
CLEO Diagnostics (ASX:COV) has revealed it’s kicked off US-based trials sussing the…
Fri, 18 Oct | Last | Change |
1:39pm | 8,291.9 | 64.0 |
Currently Trading at Fri, 18 Oct 1:42pm |
S&P/ASX Sm. Ords. | 3,200.9 | 28.2 | 0.87% |
All Ordinaries | 8,562.4 | 61.7 | 0.72% |
S&P/ASX 100 | 6,963.9 | 53.2 | 0.76% |
OVT | OVANTI LIMITED | 2.5¢ | 78.6% |
IRX | INHALERX LIMITED | 3.5¢ | 59.1% |
SLM | SOLIS MINERALS LTD. | 12.5¢ | 28.9% |
MOV | MOVE LOGISTICS GROUP LIMITED | 21.0¢ | 36.4% |
PER | PERCHERON THERAPEUTICS LIMITED | 8.9¢ | 34.1% |
LVH | LIVEHIRE LIMITED | 3.2¢ | 20.0% |